Your browser doesn't support javascript.
loading
Author Correction: Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.
Malla, Sudhir B; Byrne, Ryan M; Lafarge, Maxime W; Corry, Shania M; Fisher, Natalie C; Tsantoulis, Petros K; Mills, Megan L; Ridgway, Rachel A; Lannagan, Tamsin R M; Najumudeen, Arafath K; Gilroy, Kathryn L; Amirkhah, Raheleh; Maguire, Sarah L; Mulholland, Eoghan J; Belnoue-Davis, Hayley L; Grassi, Elena; Viviani, Marco; Rogan, Emily; Redmond, Keara L; Sakhnevych, Svetlana; McCooey, Aoife J; Bull, Courtney; Hoey, Emily; Sinevici, Nicoleta; Hall, Holly; Ahmaderaghi, Baharak; Domingo, Enric; Blake, Andrew; Richman, Susan D; Isella, Claudio; Miller, Crispin; Bertotti, Andrea; Trusolino, Livio; Loughrey, Maurice B; Kerr, Emma M; Tejpar, Sabine; Maughan, Timothy S; Lawler, Mark; Campbell, Andrew D; Leedham, Simon J; Koelzer, Viktor H; Sansom, Owen J; Dunne, Philip D.
Afiliación
  • Malla SB; The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Byrne RM; The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Lafarge MW; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Corry SM; The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Fisher NC; The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Tsantoulis PK; Faculty of Medicine, Université de Genève, Geneva, Switzerland.
  • Mills ML; Cancer Research UK Scotland Institute, Glasgow, UK.
  • Ridgway RA; Cancer Research UK Scotland Institute, Glasgow, UK.
  • Lannagan TRM; Cancer Research UK Scotland Institute, Glasgow, UK.
  • Najumudeen AK; Cancer Research UK Scotland Institute, Glasgow, UK.
  • Gilroy KL; Cancer Research UK Scotland Institute, Glasgow, UK.
  • Amirkhah R; The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Maguire SL; The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Mulholland EJ; Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Belnoue-Davis HL; Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Grassi E; Candiolo Cancer Institute, FPO IRCCS, Candiolo, Torino, Italy.
  • Viviani M; Department of Oncology, University of Torino, Candiolo, Torino, Italy.
  • Rogan E; Candiolo Cancer Institute, FPO IRCCS, Candiolo, Torino, Italy.
  • Redmond KL; Department of Oncology, University of Torino, Candiolo, Torino, Italy.
  • Sakhnevych S; The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • McCooey AJ; The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Bull C; The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Hoey E; The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Sinevici N; The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Hall H; The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Ahmaderaghi B; The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Domingo E; Cancer Research UK Scotland Institute, Glasgow, UK.
  • Blake A; School of Electronics, Electrical Engineering and Computer Science, Queen's University Belfast, Belfast, UK.
  • Richman SD; Department of Oncology, University of Oxford, Oxford, Oxfordshire, UK.
  • Isella C; Department of Oncology, University of Oxford, Oxford, Oxfordshire, UK.
  • Miller C; Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
  • Bertotti A; Candiolo Cancer Institute, FPO IRCCS, Candiolo, Torino, Italy.
  • Trusolino L; Department of Oncology, University of Torino, Candiolo, Torino, Italy.
  • Loughrey MB; Cancer Research UK Scotland Institute, Glasgow, UK.
  • Kerr EM; School of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Tejpar S; Candiolo Cancer Institute, FPO IRCCS, Candiolo, Torino, Italy.
  • Maughan TS; Candiolo Cancer Institute, FPO IRCCS, Candiolo, Torino, Italy.
  • Lawler M; Department of Oncology, University of Torino, Candiolo, Torino, Italy.
  • Campbell AD; The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Leedham SJ; Department of Cellular Pathology, Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast, UK.
  • Koelzer VH; The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Sansom OJ; Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
Nat Genet ; 56(6): 1321, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38831011
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article